Cancer News and Research

Latest Cancer News and Research

Swine flu vaccine distribution to New York companies causes uproar

The distribution of swine flu vaccines to big name companies in New York has caused an uproar as people complain that children and health care workers should receive top priority. The New York Times reports: "New York City health officials have distributed small amounts of the swine flu vaccine to some major New York companies, including Wall Street banks like Goldman Sachs and Citigroup, even as shortages continue.

6 Nov 2009

Gonorrhea medication may help fight cancer

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.

6 Nov 2009

Dems tout AMA, AARP endorsements of house health bill

ABC News: "Even as a wave of conservative protestors took over Capitol Hill, House Democrats' health care bill picked up the support of several influential organizations that could turn the tide in their favor among the most concerned groups: medical professionals and senior citizens.

6 Nov 2009

AARP urge Idaho's U.S. Representatives to support health care reform legislation

As the debate over health care reform reaches a fevered pitch and the House readies to vote on critical health care reform legislation in the coming days - AARP is calling on Idaho's U.S. Representatives to support the bill. The AARP-backed Affordable Health Care for America Act (H.R. 3962), which will close the Medicare prescription drug "doughnut hole" and tackle soaring insurance premiums, serves to help hundreds of thousands of Idahoans.

6 Nov 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

6 Nov 2009

Marriott hotels continues to support Children’s Miracle Network hospitals, hosts benefit Torch Relay

Representatives from Marriott hotels throughout the Washington, DC, area, along with co-workers, customers friends and family, joined forces last week to participate in a Torch Relay to benefit Children’s Miracle Network.

6 Nov 2009

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.

6 Nov 2009

Third-quarter 2009 financial results announced by Inhibitex

Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

UTSA releases its newest research numbers

The University of Texas at San Antonio (UTSA) released its newest research numbers today, reporting a 34% increase to $46,521,487 in total research spending for the Sept. 1, 2008 – Aug. 31, 2009 fiscal year (FY 09) over the previous fiscal year, when research spending totaled $34,601,444. The statistic is up 97% from just five years ago, when UTSA’s total research expenditures were $23,605,844.

6 Nov 2009

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.

6 Nov 2009

"Doctor's Orders" to explore trends in health and medicine

The partnership between ABC News and MedPage Today entered a new phase with the November 1 premiere of "Doctor's Orders," a featured series on Good Morning America Weekend.

6 Nov 2009

Endothelin increases T cells in the kidneys leading to renal injury

A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both.

6 Nov 2009

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Results of a long QT syndrome (LQTS) study published in the current issue of Circulation play an important role in understanding genetic testing's role in diagnosing disease, according to the senior author, Michael Ackerman, M.D., Ph.D. A pediatric cardiologist at Mayo Clinic, Dr. Ackerman directs Mayo's Long QT Syndrome Clinic and is the director of the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory.

6 Nov 2009

Future for magnetic nanoparticles appears even brighter

Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade.

6 Nov 2009

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.

6 Nov 2009

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

New Haven, Conn.-Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

6 Nov 2009

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).

6 Nov 2009

New breast reconstruction surgery for women

Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too.

6 Nov 2009

Non-invasive "optical biopsy" to detect breast cancer

Most biopsies following mammograms reveal benign abnormalities, not cancer.

6 Nov 2009

Cancer News and Research

Latest Cancer News and Research

Swine flu vaccine distribution to New York companies causes uproar

Gonorrhea medication may help fight cancer

Dems tout AMA, AARP endorsements of house health bill

AARP urge Idaho's U.S. Representatives to support health care reform legislation

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Marriott hotels continues to support Children’s Miracle Network hospitals, hosts benefit Torch Relay

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

Third-quarter 2009 financial results announced by Inhibitex

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

UTSA releases its newest research numbers

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

"Doctor's Orders" to explore trends in health and medicine

Endothelin increases T cells in the kidneys leading to renal injury

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Future for magnetic nanoparticles appears even brighter

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

New breast reconstruction surgery for women

Non-invasive "optical biopsy" to detect breast cancer

Cancer Research - Second Edition eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in